APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Parenteral PrEP

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Parenteral PrEP Industry Growth and Trends Forecast to 2032

Report ID 174022380128 December 202577 pages

Choose your research edition.

Industry ResearchParenteral PrEP Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral PrEP Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Parenteral PrEP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral PrEP Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral PrEP Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Parenteral PrEP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Parenteral PrEP include Gilead Sciences and ViiV Healthcare among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Parenteral PrEP market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Parenteral PrEP market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Parenteral PrEP market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Parenteral PrEP.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Parenteral PrEP market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Parenteral PrEP Market by Company

Gilead Sciences

ViiV Healthcare

Parenteral PrEP Segment by Type

Cabotegravir

Lenacapavir

Other

Parenteral PrEP Segment by Application

Subcutaneous Use

Intramuscular Use

Parenteral PrEP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral PrEP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral PrEP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral PrEP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Parenteral PrEP manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Parenteral PrEP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cabotegravir Table 2. Major Company of Lenacapavir Table 3. Major Company of Other Table 4. Global Parenteral PrEP Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 6. Global Parenteral PrEP Sales Market Share in Volume by Type (2021-2026) Table 7. Global Parenteral PrEP Sales by Type (2021-2026) & (US$ Million) Table 8. Global Parenteral PrEP Sales Market Share in Value by Type (2021-2026) Table 9. Global Parenteral PrEP Price by Type (2021-2026) & (US$/Unit) Table 10. Global Parenteral PrEP Sales by Type (2027-2032) & (K Units) Table 11. Global Parenteral PrEP Sales Market Share in Volume by Type (2027-2032) Table 12. Global Parenteral PrEP Sales by Type (2027-2032) & (US$ Million) Table 13. Global Parenteral PrEP Sales Market Share in Value by Type (2027-2032) Table 14. Global Parenteral PrEP Price by Type (2027-2032) & (US$/Unit) Table 15. North America Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 16. North America Parenteral PrEP Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 18. Europe Parenteral PrEP Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Parenteral PrEP Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 22. Latin America Parenteral PrEP Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Parenteral PrEP Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Parenteral PrEP Sales by Type (2021-2026) & (US$ Million) Table 25. Parenteral PrEP Industry Trends Table 26. Parenteral PrEP Industry Drivers Table 27. Parenteral PrEP Industry Opportunities and Challenges Table 28. Parenteral PrEP Industry Restraints Table 29. Global Parenteral PrEP Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Parenteral PrEP Revenue Market Share by Company (2021-2026) Table 31. Global Parenteral PrEP Sales by Company (2021-2026) & (K Units) Table 32. Global Parenteral PrEP Sales Share by Company (2021-2026) Table 33. Global Parenteral PrEP Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Parenteral PrEP Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Parenteral PrEP Major Company Production Sites and Headquarters Table 36. Global Parenteral PrEP Company, Product Type & Application Table 37. Global Parenteral PrEP Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Parenteral PrEP by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Parenteral PrEP Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Parenteral PrEP Sales by Region (2021-2026) & (K Units) Table 42. Global Parenteral PrEP Sales Market Share in Volume by Region (2021-2026) Table 43. Global Parenteral PrEP Sales by Region (2021-2026) & (US$ Million) Table 44. Global Parenteral PrEP Sales Market Share in Value by Region (2021-2026) Table 45. Global Parenteral PrEP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Parenteral PrEP Sales by Region (2027-2032) & (K Units) Table 47. Global Parenteral PrEP Sales Market Share in Volume by Region (2027-2032) Table 48. Global Parenteral PrEP Sales by Region (2027-2032) & (US$ Million) Table 49. Global Parenteral PrEP Sales Market Share in Value by Region (2027-2032) Table 50. Global Parenteral PrEP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Parenteral PrEP Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 53. Global Parenteral PrEP Sales Market Share in Volume by Application (2021-2026) Table 54. Global Parenteral PrEP Sales by Application (2021-2026) & (US$ Million) Table 55. Global Parenteral PrEP Sales Market Share in Value by Application (2021-2026) Table 56. Global Parenteral PrEP Price by Application (2021-2026) & (US$/Unit) Table 57. Global Parenteral PrEP Sales by Application (2027-2032) & (K Units) Table 58. Global Parenteral PrEP Sales Market Share in Volume by Application (2027-2032) Table 59. Global Parenteral PrEP Sales by Application (2027-2032) & (US$ Million) Table 60. Global Parenteral PrEP Sales Market Share in Value by Application (2027-2032) Table 61. Global Parenteral PrEP Price by Application (2027-2032) & (US$/Unit) Table 62. North America Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 63. North America Parenteral PrEP Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 65. Europe Parenteral PrEP Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Parenteral PrEP Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 69. Latin America Parenteral PrEP Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Parenteral PrEP Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Parenteral PrEP Sales by Application (2021-2026) & (US$ Million) Table 72. Gilead Sciences Company Information Table 73. Gilead Sciences Business Overview Table 74. Gilead Sciences Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Gilead Sciences Parenteral PrEP Product Portfolio Table 76. Gilead Sciences Recent Development Table 77. ViiV Healthcare Company Information Table 78. ViiV Healthcare Business Overview Table 79. ViiV Healthcare Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. ViiV Healthcare Parenteral PrEP Product Portfolio Table 81. ViiV Healthcare Recent Development Table 82. North America Parenteral PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 83. North America Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 84. North America Parenteral PrEP Sales Market Share by Country (2021-2026) Table 85. North America Parenteral PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 86. North America Parenteral PrEP Sales Market Share Forecast by Country (2027-2032) Table 87. North America Parenteral PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Parenteral PrEP Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Parenteral PrEP Market Share by Country (2021-2026) Table 90. North America Parenteral PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Parenteral PrEP Market Share Forecast by Country (2027-2032) Table 92. Europe Parenteral PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. Europe Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 94. Europe Parenteral PrEP Sales Market Share by Country (2021-2026) Table 95. Europe Parenteral PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 96. Europe Parenteral PrEP Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Parenteral PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Parenteral PrEP Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Parenteral PrEP Market Share by Country (2021-2026) Table 100. Europe Parenteral PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Parenteral PrEP Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Parenteral PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 104. Asia-Pacific Parenteral PrEP Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Parenteral PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 106. Asia-Pacific Parenteral PrEP Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Parenteral PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Parenteral PrEP Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Parenteral PrEP Market Share by Country (2021-2026) Table 110. Asia-Pacific Parenteral PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Parenteral PrEP Market Share Forecast by Country (2027-2032) Table 112. Latin America Parenteral PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Latin America Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 114. Latin America Parenteral PrEP Sales Market Share by Country (2021-2026) Table 115. Latin America Parenteral PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 116. Latin America Parenteral PrEP Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Parenteral PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Parenteral PrEP Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Parenteral PrEP Market Share by Country (2021-2026) Table 120. Latin America Parenteral PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Parenteral PrEP Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Parenteral PrEP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Parenteral PrEP Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Parenteral PrEP Sales Forecast by Country (2027-2032) & (K Units) Table 126. Middle East and Africa Parenteral PrEP Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Parenteral PrEP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Parenteral PrEP Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Parenteral PrEP Market Share by Country (2021-2026) Table 130. Middle East and Africa Parenteral PrEP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Parenteral PrEP Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Parenteral PrEP Distributors List Table 135. Parenteral PrEP Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Parenteral PrEP Image Figure 2. Global Parenteral PrEP Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral PrEP Market Size (2021-2032) & (US$ Million) Figure 4. Global Parenteral PrEP Sales (2021-2032) & (K Units) Figure 5. Cabotegravir Image Figure 6. Global Cabotegravir Sales YoY Growth (2021-2032) & (K Units) Figure 7. Lenacapavir Image Figure 8. Global Lenacapavir Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Parenteral PrEP Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Parenteral PrEP Market Share by Type 2025 VS 2032 Figure 13. North America Parenteral PrEP Sales Market Share in Volume by Type in 2025 Figure 14. North America Parenteral PrEP Sales Market Share in Value by Type in 2025 Figure 15. Europe Parenteral PrEP Sales Market Share in Volume by Type in 2025 Figure 16. Europe Parenteral PrEP Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Parenteral PrEP Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Parenteral PrEP Sales Market Share in Value by Type in 2025 Figure 19. Latin America Parenteral PrEP Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Parenteral PrEP Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Parenteral PrEP Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Parenteral PrEP Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Parenteral PrEP Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Subcutaneous Use Image Figure 26. Global Subcutaneous Use Sales YoY Growth (2021-2032) & (K Units) Figure 27. Intramuscular Use Image Figure 28. Global Intramuscular Use Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Parenteral PrEP Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Parenteral PrEP Market Share by Application 2025 VS 2032 Figure 31. North America Parenteral PrEP Sales Market Share in Volume by Application in 2025 Figure 32. North America Parenteral PrEP Sales Market Share in Value by Application in 2025 Figure 33. Europe Parenteral PrEP Sales Market Share in Volume by Application in 2025 Figure 34. Europe Parenteral PrEP Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Parenteral PrEP Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Parenteral PrEP Sales Market Share in Value by Application in 2025 Figure 37. Latin America Parenteral PrEP Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Parenteral PrEP Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Parenteral PrEP Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Parenteral PrEP Sales Market Share in Value by Application in 2025 Figure 41. North America Parenteral PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Parenteral PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Parenteral PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Parenteral PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Parenteral PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Parenteral PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Parenteral PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Parenteral PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Parenteral PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Parenteral PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Parenteral PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Parenteral PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Parenteral PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Parenteral PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Parenteral PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Parenteral PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Parenteral PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Parenteral PrEP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Parenteral PrEP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Parenteral PrEP Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Parenteral PrEP Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Parenteral PrEP Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Cabotegravir
  • Lenacapavir
  • Other
Applications
  • Subcutaneous Use
  • Intramuscular Use
Companies covered
  • Gilead Sciences
  • ViiV Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Parenteral PrEP Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Parenteral PrEP Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Parenteral PrEP Market by Type
  6. 1.3.1 Cabotegravir
  7. 1.3.2 Lenacapavir
  8. 1.3.3 Other
  9. 1.4 Global Parenteral PrEP Market Size by Type
  10. 1.4.1 Global Parenteral PrEP Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Parenteral PrEP Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Parenteral PrEP Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Parenteral PrEP Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Parenteral PrEP Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Parenteral PrEP Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Parenteral PrEP Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Parenteral PrEP Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Parenteral PrEP Industry Trends
  2. 2.2 Parenteral PrEP Industry Drivers
  3. 2.3 Parenteral PrEP Industry Opportunities and Challenges
  4. 2.4 Parenteral PrEP Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Parenteral PrEP Revenue (2021-2026)
  2. 3.2 Global Top Players by Parenteral PrEP Sales (2021-2026)
  3. 3.3 Global Top Players by Parenteral PrEP Price (2021-2026)
  4. 3.4 Global Parenteral PrEP Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Parenteral PrEP Major Company Production Sites & Headquarters
  6. 3.6 Global Parenteral PrEP Company, Product Type & Application
  7. 3.7 Global Parenteral PrEP Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Parenteral PrEP Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Parenteral PrEP Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Parenteral PrEP Tier 1, Tier 2, and Tier 3
4 Parenteral PrEP Regional Status and Outlook
  1. 4.1 Global Parenteral PrEP Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Parenteral PrEP Historic Market Size by Region
  3. 4.2.1 Global Parenteral PrEP Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Parenteral PrEP Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Parenteral PrEP Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Parenteral PrEP Forecasted Market Size by Region
  7. 4.3.1 Global Parenteral PrEP Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Parenteral PrEP Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Parenteral PrEP Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Parenteral PrEP by Application
  1. 5.1 Parenteral PrEP Market by Application
  2. 5.1.1 Subcutaneous Use
  3. 5.1.2 Intramuscular Use
  4. 5.2 Global Parenteral PrEP Market Size by Application
  5. 5.2.1 Global Parenteral PrEP Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Parenteral PrEP Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Parenteral PrEP Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Parenteral PrEP Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Parenteral PrEP Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Parenteral PrEP Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Parenteral PrEP Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Parenteral PrEP Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Gilead Sciences
  2. 6.1.1 Gilead Sciences Company Information
  3. 6.1.2 Gilead Sciences Business Overview
  4. 6.1.3 Gilead Sciences Parenteral PrEP Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Gilead Sciences Parenteral PrEP Product Portfolio
  6. 6.1.5 Gilead Sciences Recent Developments
  7. 6.2 ViiV Healthcare
  8. 6.2.1 ViiV Healthcare Company Information
  9. 6.2.2 ViiV Healthcare Business Overview
  10. 6.2.3 ViiV Healthcare Parenteral PrEP Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ViiV Healthcare Parenteral PrEP Product Portfolio
  12. 6.2.5 ViiV Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Parenteral PrEP Sales by Country
  2. 7.1.1 North America Parenteral PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Parenteral PrEP Sales by Country (2021-2026)
  4. 7.1.3 North America Parenteral PrEP Sales Forecast by Country (2027-2032)
  5. 7.2 North America Parenteral PrEP Market Size by Country
  6. 7.2.1 North America Parenteral PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Parenteral PrEP Market Size by Country (2021-2026)
  8. 7.2.3 North America Parenteral PrEP Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Parenteral PrEP Sales by Country
  2. 8.1.1 Europe Parenteral PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Parenteral PrEP Sales by Country (2021-2026)
  4. 8.1.3 Europe Parenteral PrEP Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Parenteral PrEP Market Size by Country
  6. 8.2.1 Europe Parenteral PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Parenteral PrEP Market Size by Country (2021-2026)
  8. 8.2.3 Europe Parenteral PrEP Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Parenteral PrEP Sales by Country
  2. 9.1.1 Asia-Pacific Parenteral PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Parenteral PrEP Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Parenteral PrEP Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Parenteral PrEP Market Size by Country
  6. 9.2.1 Asia-Pacific Parenteral PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Parenteral PrEP Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Parenteral PrEP Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Parenteral PrEP Sales by Country
  2. 10.1.1 South America Parenteral PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Parenteral PrEP Sales by Country (2021-2026)
  4. 10.1.3 South America Parenteral PrEP Sales Forecast by Country (2027-2032)
  5. 10.2 South America Parenteral PrEP Market Size by Country
  6. 10.2.1 South America Parenteral PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Parenteral PrEP Market Size by Country (2021-2026)
  8. 10.2.3 South America Parenteral PrEP Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Parenteral PrEP Sales by Country
  2. 11.1.1 Middle East and Africa Parenteral PrEP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Parenteral PrEP Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Parenteral PrEP Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Parenteral PrEP Market Size by Country
  6. 11.2.1 Middle East and Africa Parenteral PrEP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Parenteral PrEP Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Parenteral PrEP Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Parenteral PrEP Value Chain Analysis
  2. 12.1.1 Parenteral PrEP Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Parenteral PrEP Production Mode & Process
  7. 12.2 Parenteral PrEP Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Parenteral PrEP Distributors
  10. 12.2.3 Parenteral PrEP Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst